We are live on ! Find out more
PCH

Polar Capital Holdings Portfolio holdings

AUM $42.4B
1-Year Est. Return 181.11%
This Fund
S&P 500
This Quarter Est. Return
+19.29%
1 Year Est. Return
+181.11%
3 Year Est. Return
+584.8%
5 Year Est. Return
+777.19%
10 Year Est. Return
–
AUM
$16.3B
AUM Growth
+$2.83B
Cap. Flow
-$1.17B
Cap. Flow %
-7.17%
Top 10 Hldgs %
36.28%
Holding
315
New
38
Increased
65
Reduced
120
Closed
39

Top Buys

Rank Stock Value
1
MU icon
Micron Technology
MU
+$135M
2
NFLX icon
Netflix
NFLX
+$114M
3
CDNS icon
Cadence Design Systems
CDNS
+$90.7M
4
TTD icon
Trade Desk
TTD
+$71.4M
5
AVGO icon
Broadcom
AVGO
+$68.3M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$164M
2
META icon
Meta Platforms (Facebook)
META
+$120M
3
NVDA icon
NVIDIA
NVDA
+$104M
4
MRVL icon
Marvell Technology
MRVL
+$81.9M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$73.9M

Sector Composition

Rank Sector Weight
1 Technology 38.21%
2 Healthcare 18.58%
3 Financials 14.62%
4 Industrials 12.42%
5 Communication Services 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WDAY icon
76
Workday
WDAY
$44.8B
$59.4M 0.36%
215,245
+24,208
+13% +$5.76M
BSX icon
77
Boston Scientific
BSX
$62.3B
$58.6M 0.36%
1,013,105
+351,659
+53% +$18.8M
MNDY icon
78
monday.com
MNDY
$4.06B
$58.5M 0.36%
311,736
-120,002
-28% -$19.3M
PDD icon
79
Pinduoduo
PDD
$113B
$57.3M 0.35%
391,378
-65,870
-14% -$7.99M
AXON
80
Axon Enterprise
AXON
$38.9B
$57.2M 0.35%
221,598
-43,866
-17% -$9.89M
MLTX icon
81
MoonLake Immunotherapeutics
MLTX
$1.06B
$56.6M 0.35%
937,115
-1,897
-0.2% -$97.8K
SUPN icon
82
Supernus Pharmaceuticals
SUPN
$2.41B
$56.1M 0.34%
1,939,365
+284,895
+17% +$7.55M
ELV icon
83
Elevance Health
ELV
$90.8B
$56.1M 0.34%
118,996
-18,348
-13% -$8.48M
ABBV icon
84
AbbVie
ABBV
$454B
$56.1M 0.34%
361,808
-5,064
-1% -$738K
RYAN icon
85
Ryan Specialty Holdings
RYAN
$4.65B
$55.4M 0.34%
1,287,500
– –
SRRK icon
86
Scholar Rock
SRRK
$6.75B
$55.3M 0.34%
2,940,672
+1,438,746
+96% +$17.9M
BRK.B icon
87
Berkshire Hathaway Class B
BRK.B
$1.1T
$55.2M 0.34%
154,786
-2,064
-1% -$724K
MELI icon
88
Mercado Libre
MELI
$96.3B
$49.6M 0.3%
31,543
+4,583
+17% +$6.5M
FAF icon
89
First American
FAF
$7.33B
$45.1M 0.28%
700,000
– –
JPM icon
90
JPMorgan Chase
JPM
$931B
$44.2M 0.27%
259,875
-1,402
-0.5% -$212K
MMYT icon
91
MakeMyTrip
MMYT
$4.75B
$43M 0.26%
915,452
+100,474
+12% +$4.24M
CRH icon
92
CRH
CRH
$58.9B
$41.8M 0.26%
604,197
-52,019
-8% -$3.14M
GLOB icon
93
Globant
GLOB
$1.63B
$40.1M 0.25%
168,508
+16,393
+11% +$3.35M
AFL icon
94
Aflac
AFL
$57.8B
$40M 0.25%
485,000
-15,000
-3% -$1.21M
HGTY icon
95
Hagerty
HGTY
$1.51B
$38.4M 0.24%
4,925,000
+343,295
+7% +$2.8M
TRUP icon
96
Trupanion
TRUP
$1.09B
$38.1M 0.23%
1,250,000
– –
PLRX icon
97
Pliant Therapeutics
PLRX
$72.4M
$36.5M 0.22%
2,015,000
+350,000
+21% +$5.32M
MMSI icon
98
Merit Medical Systems
MMSI
$5.16B
$36.3M 0.22%
478,342
– –
ABT icon
99
Abbott
ABT
$176B
$35.8M 0.22%
+325,000
New +$32.5M
LIN icon
100
Linde
LIN
$214B
$35.5M 0.22%
86,317
-5,385
-6% -$2.12M
2 3
4
5 6

Similar funds

Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
Empower Advisory Group
Empower Advisory Group Greenwood Village, Colorado $41.9B AUM 18.91% 1-Year Est. Return
GAM
Gotham Asset Management New York $43B AUM 34.97% 1-Year Est. Return
Newport Trust Company
Newport Trust Company Washington, District of Columbia $41.5B AUM 16.76% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $40.6B AUM 38.65% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return

Polar Capital Holdings's Q4 2023 Portfolio in Review

As of Q4 2023, Polar Capital Holdings held 315 positions worth $16.3B, up 21% from $13.5B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Polar Capital Holdings withdrew a net $1.17B in Q4 2023, closing 39 positions and reducing 120 holdings. Its most notable exit was Indivior Pharmaceuticals, an estimated $60.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 42% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Polar Capital Holdings opened a new position in Netflix worth $127M.

  • Polar Capital Holdings's largest Q4 2023 buy was Netflix: 2,609,240 shares worth $127M.
  • Polar Capital Holdings added most to Micron Technology in Q4 2023, an estimated $135M increase.
  • Polar Capital Holdings's biggest Q4 2023 reduction was Microsoft, cutting an estimated $164M.
  • Polar Capital Holdings fully exited Indivior Pharmaceuticals in Q4 2023, selling an estimated $60.5M.
  • Polar Capital Holdings's ten largest holdings make up 36% of its $16.3B portfolio in Q4 2023.
  • Polar Capital Holdings opened 38 new positions and closed 39 in Q4 2023.
  • Polar Capital Holdings's portfolio value rose 21% quarter-over-quarter to $16.3B.

Based on Polar Capital Holdings's 13F filing for Q4 2023, filed 14 Feb 2024.